UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000024257
Receipt No. R000027928
Scientific Title Association of changes in dyspnea, lung function, and physical activity by Indacaterol/Glycopyrronium combination in patients with COPD
Date of disclosure of the study information 2016/10/10
Last modified on 2018/11/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Association of changes in dyspnea, lung function, and physical activity by Indacaterol/Glycopyrronium combination in patients with COPD
Acronym Changes in lung function and physical activity by LAMA/LABA therapy in COPD
Scientific Title Association of changes in dyspnea, lung function, and physical activity by Indacaterol/Glycopyrronium combination in patients with COPD
Scientific Title:Acronym Changes in lung function and physical activity by LAMA/LABA therapy in COPD
Region
Japan

Condition
Condition COPD
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This trial is aimed to assess the association of changes in dyspnea, lung function, and physical activity by bronchodilation therapy in patients with COPD
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The primary objective of this trial is to investigate the change in PA over a 12-week in response to QVA-149 (long-acting beta2 agonists (LABA)/long-acting muscarinic receptor antagonists (LAMA)) therapy in patients with COPD.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 QVA-149 (long-acting beta2 agonists (LABA)/long-acting muscarinic receptor antagonists (LAMA)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Written informed consent must be obtained before any assessment is performed
2) Aged >=40 years with mild-to-moderate stable COPD
3) A post-bronchodilator FEV1 of >=50% of the predicted normal, have a post-bronchodilator FEV1 to FVC ratio of <0.70
4) Either current smokers or ex-smokers with a smoking history of >=10 pack-years
5) A modified Medical Research Council (mMRC) dyspnea scale grade of at least 1
Key exclusion criteria 1) Moderate-to-severe COPD exacerbation (requiring antibiotics, systemic steroids or hospitalization) within the 4 weeks before the screening
2) Requiring LABA and LAMA combination therapy
3) Requiring long-term oxygen therapy
4) Requiring short-acting beta2-agonista (SABA) relief use of more than 8 puffs/day
5) Concomitant pulmonary disease including asthma (FeNO<50ppb at baseline)
6) Any physical disorder that would prevent the patient from being able to complete the assessments
7) Long QT syndrome at screening, or a clinically significant electrocardiogram abnormality
8) History of closed angle glaucoma, and/or ischuria due to prostatic disease
9) There is a history of hypersensitivity to components of the Urutiburo
Target sample size 45

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name kazuto Matsunaga
Organization Graduate School of Medicine, Yamaguchi University
Division name Department of Respiratory Medicine and Infectious Disease
Zip code
Address 1-1-1 Minami-kogushi, Ube, Yamaguchi
TEL 0836-85-3123
Email kokyuki@yamaguchi-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name kazuto Matsunaga
Organization Graduate School of Medicine, Yamaguchi University
Division name Department of Respiratory Medicine and Infectious Disease
Zip code
Address 1-1-1 Minami-kogushi, Ube, Yamaguchi
TEL 0836-85-3123
Homepage URL
Email kokyuki@yamaguchi-u.ac.jp

Sponsor
Institute Yamaguchi University
Institute
Department

Funding Source
Organization Novartis pharma
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 10 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2016 Year 06 Month 27 Day
Date of IRB
Anticipated trial start date
2016 Year 12 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 10 Month 02 Day
Last modified on
2018 Year 11 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027928

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.